AP CONTENT SPECIFICATIONS
References
2. CNS

Van den Bent MJ and Kros JM:Predictive and prognostic markers in neuro-oncology. Jour. Neuropath & Exptl. Neurol. (JNEN) 66:1074- 1081, December 2007. http://www.ncbi.nlm.nih.gov/pubmed/18090916?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Gupta M, Djalilvand A, Brat DJ. Clarifying the Diffuse Gliomas. An Update on the Morphologic Features and Markers that Discriminate Oligodendroglioma From Astrocytoma. Am J. Clin Pathol 2005; 124: 755-768 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16203285&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Aldape K, et al. Clinicopathologic Aspects of 1p/19q Loss and the Diagnosis of Oligodendroglioma. Arch Path Lab Med. 2007;131:242-251 http://www.ncbi.nlm.nih.gov/pubmed/17284109?ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum


This page was last modified on February 8, 2008.